Peptides DB
Research-centric peptide and protocol reference hub
Study 83 of 85Glutathione (GSH) literaturebiorxiv-preprint · Observational2026

NRF2-driven thiol metabolism creates a selective vulnerability to selenite

NRF2-driven metabolic changes may create vulnerabilities in certain lung cancers, making them potentially susceptible to selenite treatment.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the glutathione (gsh) corpus
7
Preclinical
70
Observational · this one
0
Open-label
4
Randomised
4
Reviews

Summary and findings

This study investigates the effects of NRF2-driven metabolic reprogramming on the vulnerability of non-small cell lung cancer cells to selenite. The research demonstrates that selenite can induce cell death in NRF2-hyperactive tumors. Notably, a selenite-rich diet suppressed tumor growth in mice.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

NRF2 hyperactivation caused by mutations in KEAP1 or NFE2L2 occurs in 20-30% of non-small cell lung cancers and confers therapy resistance. Here we show that NRF2-driven metabolic reprogramming creates a selective vulnerability to selenite. NRF2-dependent thiol export promotes the extracellular reduction of selenite to selenide. Our data support a model in which selenide enters cells and reaches mitochondria, where sulfide-quinone oxidoreductase uses selenide and glutathione to generate the selenopersulfide GS-SeH. A four-hour pulse of selenite was sufficient to induce cell death after washout, consistent with a selenium redox cycle that consumes NADPH and regenerates selenide. Within hours, selenite abolished aconitase activity and impaired mitochondrial respiration. The resulting cell death occurred independently of apoptosis, ferroptosis, pyroptosis, necroptosis and disulfidptosis. In mice, a selenite-rich diet selectively suppressed the growth of NRF2-hyperactive tumors. These findings identify an NRF2-driven metabolic vulnerability and support further investigation of selenite as a therapeutic strategy for NRF2-hyperactive cancers.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Glutathione (GSH) corpus

CEvaluation of the Gastroprotective and Therapeutic Effects of Arthrospira platensis Against Ethanol-Induced Gastric Ulceration and Associated Oxidative Damage in Ratsbiorxiv-preprint · 2026 · n=54 · Intra-gastric administration of Spirulina (500 mg/kg) significantly decreased the ulcer index relative to the ulcer control group (p < 0.05).AnimalCNeuronal Aralar/AGC1 deficiency impairs social behavior through dopaminergic and redox dysfunction and is rescued by β-hydroxybutyratebiorxiv-preprint · 2023 · BHB treatment restored sociability, normalized striatal metabolic alterations, reduced oxidative stress, and abolished genotype-dependent neurochemical abnormalities.AnimalBSerum Heme Oxygenase-1 and Antioxidant Enzyme Levels in Vitiligo: Relationship with Disease Activity and Response to Narrowband UVB Phototherapy. A Prospective Studybiorxiv-preprint · 2026 · Serum HO-1 increased from median 0.49 to 0.80 ng/mL, p=0.036.HumanCBlood Cell Secretome Associated with Remote Ischemic Conditioning: Proteomic Profiling of Processes Linked to Neuroprotection in Experimental Strokebiorxiv-preprint · 2026 · Infarct volume reduced from 62.5% to 41.6% with TS treatment.AnimalDLipid organization in health and disease.Cell metabolism · 2026—BMicrobiome-wide PheWAS links gut microbial SNVs to health and exposures.Nature · 2026 · 940 independent associations across 69 host factors.Human